tirzepatide shortage fda update Announced Removal of from the Drug List New Study Finds Compounded GLP-1s

While it is not yet available, ongoing trials suggest it may become a game-changer in the fight against obesity

STEER fills that gap, even if the design is observational rather than randomized

Inconsistent absorption from poor technique can create mini-spikes in drug levels that provoke GI reactions

Khng c tc dng ph trn da

It is also enough of a guardrail that the protocol produces the response we are paying for

A separate rapid review published in Obesity Reviews in late 2025 by Jebeile and colleagues, which analyzed 25 studies, found that binge eating episodes and prevalence were reduced following treatment with liraglutide and semaglutide